Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 721

1.

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.

Gatto F, Feelders RA, Franck SE, van Koetsveld PM, Dogan F, Kros JM, Neggers SJCMM, van der Lely AJ, Lamberts SWJ, Ferone D, Hofland LJ.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2009-2018. doi: 10.1210/jc.2017-00135.

PMID:
28323931
2.

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.

Öberg K, Lamberts SW.

Endocr Relat Cancer. 2016 Dec;23(12):R551-R566. Epub 2016 Oct 3. Review.

3.

Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland.

Pivonello R, Waaijers M, Kros JM, Pivonello C, de Angelis C, Cozzolino A, Colao A, Lamberts SW, Hofland LJ.

Endocrine. 2016 Oct 13. [Epub ahead of print]

PMID:
27738887
4.

[From annual check-up to annual appraisal: personalised diabetes care].

Rutten GE, van Vugt HA, de Weerdt I, Lamberts SW, de Koning EJ.

Ned Tijdschr Geneeskd. 2016;160(0):D342. Dutch.

PMID:
27405571
5.

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells.

Veenstra MJ, van Koetsveld PM, Dogan F, Farrell WE, Feelders RA, Lamberts SW, de Herder WW, Vitale G, Hofland LJ.

Oncotarget. 2016 May 19. doi: 10.18632/oncotarget.9462. [Epub ahead of print]

6.

Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly.

Gatto F, Biermasz NR, Feelders RA, Kros JM, Dogan F, van der Lely AJ, Neggers SJ, Lamberts SW, Pereira AM, Ferone D, Hofland LJ.

Eur J Endocrinol. 2016 May;174(5):651-62. doi: 10.1530/EJE-15-0391. Epub 2016 Feb 17.

7.

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells.

van Adrichem RC, de Herder WW, Kamp K, Brugts MP, de Krijger RR, Sprij-Mooij DM, Lamberts SW, van Koetsveld PM, Janssen JA, Hofland LJ.

Neuroendocrinology. 2016;103(6):815-25. doi: 10.1159/000444280. Epub 2016 Feb 2.

8.

Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.

De Martino MC, van Koetsveld PM, Feelders RA, Lamberts SW, de Herder WW, Colao A, Pivonello R, Hofland LJ.

Endocrine. 2016 Jun;52(3):664-7. doi: 10.1007/s12020-015-0818-0. Epub 2015 Dec 8. No abstract available.

PMID:
26645813
9.

Cushing's syndrome: an update on current pharmacotherapy and future directions.

Creemers SG, Hofland LJ, Lamberts SW, Feelders RA.

Expert Opin Pharmacother. 2015;16(12):1829-44. doi: 10.1517/14656566.2015.1061995. Epub 2015 Jul 1. Review.

PMID:
26133755
10.

Changes in circulating IGF1 receptor stimulating activity do not parallel changes in total IGF1 during GH treatment of GH-deficient adults.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA.

Eur J Endocrinol. 2015 Aug;173(2):119-27. doi: 10.1530/EJE-15-0048. Epub 2015 May 6.

11.

Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.

Quax RA, Koper JW, Huisman AM, Weel A, Hazes JM, Lamberts SW, Feelders RA.

Rheumatol Int. 2015 Aug;35(8):1325-33. doi: 10.1007/s00296-015-3235-z. Epub 2015 Feb 28.

12.

The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA.

J Clin Endocrinol Metab. 2015 Jan;100(1):309-16. doi: 10.1210/jc.2014-2558.

PMID:
25337924
13.

Advances in the assessment of cortisol exposure and sensitivity.

Wester VL, Lamberts SW, van Rossum EF.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):306-11. doi: 10.1097/MED.0000000000000077. Review.

PMID:
24983396
14.

Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.

De Martino MC, Feelders RA, de Herder WW, van Koetsveld PM, Dogan F, Janssen JA, Waaijers AM, Pivonello C, Lamberts SW, Colao A, de Krijger RR, Pivonello R, Hofland LJ.

Endocr Relat Cancer. 2014 Aug;21(4):601-13. doi: 10.1530/ERC-13-0112. Epub 2014 Jun 2.

15.

Radiometrical, hormonal and biological correlates of skeletal growth in the female rat from birth to senescence.

del Pozo E, Janner M, Mackenzie AR, Arampatzis S, Dixon AK, Perrelet R, Ruch W, Lippuner K, Zapf J, Lamberts SW, Mullis PE.

Growth Horm IGF Res. 2014 Apr-Jun;24(2-3):83-8. doi: 10.1016/j.ghir.2014.03.003. Epub 2014 Mar 26.

PMID:
24735836
16.

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life.

Varewijck AJ, van der Lely AJ, Neggers SJ, Lamberts SW, Hofland LJ, Janssen JA.

Endocr Connect. 2014 Apr 15;3(2):85-92. doi: 10.1530/EC-14-0028. Print 2014.

17.

Expert consensus document: A consensus on the medical treatment of acromegaly.

Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, van der Lely AJ, Strasburger CJ, Lamberts SW, Ho KK, Casanueva FF, Melmed S; Acromegaly Consensus Group.

Nat Rev Endocrinol. 2014 Apr;10(4):243-8. doi: 10.1038/nrendo.2014.21. Epub 2014 Feb 25. Review.

PMID:
24566817
18.

β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.

Gatto F, Feelders R, van der Pas R, Kros JM, Dogan F, van Koetsveld PM, van der Lelij AJ, Neggers SJ, Minuto F, de Herder W, Lamberts SW, Ferone D, Hofland LJ.

Endocrinology. 2013 Dec;154(12):4715-25. doi: 10.1210/en.2013-1672. Epub 2013 Oct 29.

PMID:
24169548
19.

Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.

van der Pas R, van Esch JH, de Bruin C, Danser AH, Pereira AM, Zelissen PM, Netea-Maier R, Sprij-Mooij DM, van den Berg-Garrelds IM, van Schaik RH, Lamberts SW, van den Meiracker AH, Hofland LJ, Feelders RA.

Eur J Endocrinol. 2014 Feb 1;170(2):181-91. doi: 10.1530/EJE-13-0477. Print 2014 Feb.

20.

Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.

van der Pas R, Feelders RA, Gatto F, de Bruin C, Pereira AM, van Koetsveld PM, Sprij-Mooij DM, Waaijers AM, Dogan F, Schulz S, Kros JM, Lamberts SW, Hofland LJ.

J Clin Endocrinol Metab. 2013 Dec;98(12):E1880-90. doi: 10.1210/jc.2013-1987. Epub 2013 Sep 30.

PMID:
24081741

Supplemental Content

Loading ...
Support Center